#digitalbiomarker — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #digitalbiomarker, aggregated by home.social.
-
#IDEA-FAST is exploring the possibility of regulatory qualification for proposed cross-disease digital measures. Typically a measure is qualified per disease/condition, but we are exploring what is required to qualify a cross-disease digital measure!
We share some insights in this paper from a qualification advice process with the European Medicines Agency (EMA)--useful for anyone else considering this challenge:
https://karger.com/dib/article/7/1/132/862649/Regulatory-Qualification-of-a-Cross-Disease -
#IDEA-FAST is exploring the possibility of regulatory qualification for proposed cross-disease digital measures. Typically a measure is qualified per disease/condition, but we are exploring what is required to qualify a cross-disease digital measure!
We share some insights in this paper from a qualification advice process with the European Medicines Agency (EMA)--useful for anyone else considering this challenge:
https://karger.com/dib/article/7/1/132/862649/Regulatory-Qualification-of-a-Cross-Disease -
#IDEA-FAST is exploring the possibility of regulatory qualification for proposed cross-disease digital measures. Typically a measure is qualified per disease/condition, but we are exploring what is required to qualify a cross-disease digital measure!
We share some insights in this paper from a qualification advice process with the European Medicines Agency (EMA)--useful for anyone else considering this challenge:
https://karger.com/dib/article/7/1/132/862649/Regulatory-Qualification-of-a-Cross-Disease -
#IDEA-FAST is exploring the possibility of regulatory qualification for proposed cross-disease digital measures. Typically a measure is qualified per disease/condition, but we are exploring what is required to qualify a cross-disease digital measure!
We share some insights in this paper from a qualification advice process with the European Medicines Agency (EMA)--useful for anyone else considering this challenge:
https://karger.com/dib/article/7/1/132/862649/Regulatory-Qualification-of-a-Cross-Disease -
#IDEA-FAST is exploring the possibility of regulatory qualification for proposed cross-disease digital measures. Typically a measure is qualified per disease/condition, but we are exploring what is required to qualify a cross-disease digital measure!
We share some insights in this paper from a qualification advice process with the European Medicines Agency (EMA)--useful for anyone else considering this challenge:
https://karger.com/dib/article/7/1/132/862649/Regulatory-Qualification-of-a-Cross-Disease -
💰The « 1 Million Dollar Question » of the day: What is a #DigitalBiomarker?
Welll, no one really seems to agree… That is a bummer!
We need to do better for such a critical definition. We need official guidance and a consensus on the definition.
See this new systematic mapping and review
⚠️ Not yet peer-reviewed ⚠️.
The preprint @medrxivpreprint https://www.medrxiv.org/content/10.1101/2023.09.01.23294897v1
-
💰The « 1 Million Dollar Question » of the day: What is a #DigitalBiomarker?
Welll, no one really seems to agree… That is a bummer!
We need to do better for such a critical definition. We need official guidance and a consensus on the definition.
See this new systematic mapping and review
⚠️ Not yet peer-reviewed ⚠️.
The preprint @medrxivpreprint https://www.medrxiv.org/content/10.1101/2023.09.01.23294897v1
-
💰The « 1 Million Dollar Question » of the day: What is a #DigitalBiomarker?
Welll, no one really seems to agree… That is a bummer!
We need to do better for such a critical definition. We need official guidance and a consensus on the definition.
See this new systematic mapping and review
⚠️ Not yet peer-reviewed ⚠️.
The preprint @medrxivpreprint https://www.medrxiv.org/content/10.1101/2023.09.01.23294897v1
-
💰The « 1 Million Dollar Question » of the day: What is a #DigitalBiomarker?
Welll, no one really seems to agree… That is a bummer!
We need to do better for such a critical definition. We need official guidance and a consensus on the definition.
See this new systematic mapping and review
⚠️ Not yet peer-reviewed ⚠️.
The preprint @medrxivpreprint https://www.medrxiv.org/content/10.1101/2023.09.01.23294897v1
-
Trial to Assess At-Home Asthma Lung Function Tests
A clinical trial is set to begin that compares monitoring of #lung functions in people with #asthma using portable #ultrasound and mobile app at home to conventional tests in a clinic.
https://sciencebusiness.technewslit.com/?p=44341
#News #Science #Business #ClinicalTrial #Spirometry #Software #CloudComputing #Algorithms #DigitalBiomarker #Smartphone #LABA
-
Trial to Assess At-Home Asthma Lung Function Tests
A clinical trial is set to begin that compares monitoring of #lung functions in people with #asthma using portable #ultrasound and mobile app at home to conventional tests in a clinic.
https://sciencebusiness.technewslit.com/?p=44341
#News #Science #Business #ClinicalTrial #Spirometry #Software #CloudComputing #Algorithms #DigitalBiomarker #Smartphone #LABA
-
Trial to Assess At-Home Asthma Lung Function Tests
A clinical trial is set to begin that compares monitoring of #lung functions in people with #asthma using portable #ultrasound and mobile app at home to conventional tests in a clinic.
https://sciencebusiness.technewslit.com/?p=44341
#News #Science #Business #ClinicalTrial #Spirometry #Software #CloudComputing #Algorithms #DigitalBiomarker #Smartphone #LABA
-
Trial to Assess At-Home Asthma Lung Function Tests
A clinical trial is set to begin that compares monitoring of #lung functions in people with #asthma using portable #ultrasound and mobile app at home to conventional tests in a clinic.
https://sciencebusiness.technewslit.com/?p=44341
#News #Science #Business #ClinicalTrial #Spirometry #Software #CloudComputing #Algorithms #DigitalBiomarker #Smartphone #LABA